2008
- May 15, 2008 - Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute » Read
- January 31, 2008 - Tigris Pharmaceuticals Appoints Pedro Granadillo to Board of Directors » Read
- January 30, 2008 - Tigris Pharmaceuticals Initiates Phase I Study of AFP-464 in Patients with Solid Tumors » Read
2007
- January 16, 2007 - Tigris Pharmaceuticals, Inc. Completes $16 Million Private Placement, Led by NGN Capital » Read
2006
- July 17, 2006 - Tigris Pharmaceuticals Broadens Oncology Pipeline With License Agreement for Phase 1 Compound From the National Institutes of Health » Read
- July 12, 2006 - Tigris Pharmaceuticals Completes License Agreements for the Exclusive Rights to Novel, Targeted Cancer Compounds Read
2005
- October 17, 2005 - Tigris Pharmaceuticals Raises $11.6 Million in Private Placement » Read
- September 22, 2005 - Binh Nguyen, M.D., Ph.D. named VP of Clinical Development and Regulatory Affairs of Tigris Pharmaceuticals » Read
- August 31, 2005 - Anne E. White named Chief Operating Officer and VP of Clinical Operations of Tigris Pharmaceuticals » Read
- August 8, 2005 - Edmundo Muniz, M.D., Ph.D. named President and CEO of Tigris Pharmaceuticals » Read
|
